Yonit Marcus, Ph.D.
Affiliations: | 2010 | Weizmann Institute of Science, Rehovot, Israel |
Area:
Histology Biology, Physiology BiologyGoogle:
"Yonit Marcus"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Yoram Shechter | grad student | 2010 | Weizmann Institute | |
| (Novel Therapy for the Metabolic Syndrome: Reversibly pegylated Angiotensin 1-7 as a long-acting pro-drug.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Marcus Y, Shefer G, Sasson K, et al. (2013) Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. Diabetes. 62: 1121-30 |
| Shechter Y, Sasson K, Marcus Y, et al. (2012) Establishing the principle of reversibility in peptide/protein and small-molecule therapy. Therapeutic Delivery. 3: 17-23 |
| Sasson K, Marcus Y, Lev-Goldman V, et al. (2010) Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 214-20 |
| Marcus Y, Sasson K, Fridkin M, et al. (2008) Turning low-molecular-weight drugs into prolonged acting prodrugs by reversible pegylation: a study with gentamicin. Journal of Medicinal Chemistry. 51: 4300-5 |
| Shechter Y, Mironchik M, Rubinraut S, et al. (2008) Reversible pegylation of insulin facilitates its prolonged action in vivo. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 70: 19-28 |